ResMed, Verily venture renamed Primasun
By HME News Staff
Updated 9:13 AM CDT, Wed April 7, 2021
SAN DIEGO – A joint venture between ResMed and Verily to study the health and financial impacts of undiagnosed and untreated sleep apnea has been renamed Primasun.
ResMed and Verily, a subsidiary of Alphabet, first joined forces in 2018.
“We need a full night’s sleep right alongside a healthy diet and regular exercise for a strong immune system, the most energy, our best mood – in essence, to be our best selves,” said Primasun CEO Jonathon Lobbins. “Only when sleep apnea stops robbing sleep from millions of Americans can we truly know how healthy we can feel and be, as well as how safe and healthy our communities and our economy can be.”
Lobbins was named CEO of Primasun in November 2020. He is longtime health care executive, with roles at Siemens, Edwards Lifesciences and Medtronic.
Comments